U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 500

1.
Chromosomal alteration patterns in PitNETs: massive losses in aggressive tumors
Maaia Margo Jentus, Leontine Bakker, Marco Verstegen, Iris Pelsma, Tom van Wezel, Dina Ruano, Ellen Kapiteijn, Stijn Crobach, Nienke Biermasz, Hans Morreau
Endocr Relat Cancer. 2025 Jan 1; 32(1): e240070. Prepublished online 2024 Oct 23. Published online 2024 Dec 19. doi: 10.1530/ERC-24-0070
PMCID:
PMC11729050
ArticlePDF–1.0M
2.
Developmental pluripotency-associated 4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell stemness
Shaista Chaudhary, Ujjal Das, Shaima Jabbar, Omkaram Gangisetty, Bénédicte Rousseau, Simon Hanft, Dipak K Sarkar
Neuro Oncol. 2025 Jan; 27(1): 123–139. Published online 2024 Aug 2. doi: 10.1093/neuonc/noae148
PMCID:
PMC11726338
ArticlePDF–25M
3.
Association between transcription factors expression and growth patterns of nonfunctioning pituitary adenomas
Jiakun Xu, Shaolin Zhang, Weijie Su, Jia Yang, Lixuan Yang, Xixi Li
Sci Rep. 2025; 15: 601. Published online 2025 Jan 2. doi: 10.1038/s41598-024-84261-y
PMCID:
PMC11696072
ArticlePDF–2.0M
4.
Genetic Landscape and Clinical Manifestations of Multiple Endocrine Neoplasia Type 1 in a Korean Cohort: A Multicenter Retrospective Analysis
Boram Kim, Seung Hun Lee, Chang Ho Ahn, Han Na Jang, Sung Im Cho, Jee-Soo Lee, Yu-Mi Lee, Su-Jin Kim, Tae-Yon Sung, Kyu Eun Lee, Woochang Lee, Jung-Min Koh, Moon-Woo Seong, Jung Hee Kim
Endocrinol Metab (Seoul) 2024 Dec; 39(6): 956–964. Published online 2024 Nov 18. doi: 10.3803/EnM.2024.2008
PMCID:
PMC11695471
ArticlePDF–622K
5.
Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing’s syndrome accompanied by hyperglycemia: a case report
Haremaru Kubo, Ryota Wada, Naohiro Sekikawa, Yasuhisa Nomura, Mutsuo Yamada, Minoru Inoue, Naoki Hattori, Yuto Yamazaki, Kazuhiro Sugimoto
Front Endocrinol (Lausanne) 2024; 15: 1498991. Published online 2024 Dec 12. doi: 10.3389/fendo.2024.1498991
PMCID:
PMC11669518
ArticlePDF–4.6M
6.
Progression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53
Nancy M. Joseph, Sarah E. Umetsu, Grace E. Kim, Merryl Terry, Arie Perry, Emily Bergsland, Sanjay Kakar
Endocr Pathol. 2024; 35(4): 325–337. Published online 2024 Nov 18. doi: 10.1007/s12022-024-09835-y
PMCID:
PMC11659342
ArticlePDF–3.9M
7.
High-Grade Progression, Sarcomatous Transformation, and/or Metastasis of Pituitary Neuroendocrine Neoplasms (PitNENs): The UCSF Experience
Merryl Terry, Minh P. Nguyen, Vivian Tang, Ekin Guney, Krishna L. Bharani, Sonika Dahiya, Ondrej Choutka, Ewa Borys, Gerald Reis, Lewis Blevins, Manish K. Aghi, Sandeep Kunwar, John DeGroot, David R. Raleigh, Melike Pekmezci, Andrew W. Bollen, Soonmee Cha, Nancy M. Joseph, Arie Perry
Endocr Pathol. 2024; 35(4): 338–348. Published online 2024 Oct 10. doi: 10.1007/s12022-024-09829-w
PMCID:
PMC11659330
ArticlePDF–2.9M
8.
A novel computational model ITHCS for enhanced prognostic risk stratification in ESCC by correcting for intratumor heterogeneity
Tong Lu, Wei Guo, Wei Guo, Wangyang Meng, Tianyi Han, Zizhen Guo, Chengqiang Li, Shugeng Gao, Youqiong Ye, Hecheng Li
Brief Bioinform. 2025 Jan; 26(1): bbae631. Published online 2024 Dec 17. doi: 10.1093/bib/bbae631
PMCID:
PMC11652613
ArticlePDF–2.9M
9.
Intravascular large B-cell lymphoma arising in the pituitary gland: A case report
Kyu Yun Jang, Ae Ri Ahn
Medicine (Baltimore) 2024 Dec 13; 103(50): e40995. Published online 2024 Dec 13. doi: 10.1097/MD.0000000000040995
PMCID:
PMC11651503
ArticlePDF–798K
10.
Advancements in Molecular Diagnosis and Pharmacotherapeutic Strategies for Invasive Pituitary Adenomas
Dingkai Xu, Ling Wang, Maohua Zheng
Immun Inflamm Dis. 2024 Dec; 12(12): e70098. Published online 2024 Dec 17. doi: 10.1002/iid3.70098
PMCID:
PMC11650491
ArticlePDF–365K
11.
The Activation of p300 Enhances the Sensitivity of Pituitary Adenomas to Dopamine Agonist Treatment by Regulating the Transcription of DRD2
Sihan Li, Xingbo Li, Quanji Wang, Qian Jiang, Zihan Wang, Linpeng Xu, Yimin Huang, Ting Lei
Int J Mol Sci. 2024 Dec; 25(23): 12483. Published online 2024 Nov 21. doi: 10.3390/ijms252312483
PMCID:
PMC11641041
ArticlePDF–9.3M
12.
Cushing’s Disease Manifestation in USP8-Mutated Corticotropinoma May Be Mediated by Interactions Between WNT Signaling and SST Trafficking
Elena Nerubenko, Pavel Ryazanov, Natalia Kuritsyna, Artem Paltsev, Oksana Ivanova, Elena Grineva, Anna Kostareva, Renata Dmitrieva, Uliana Tsoy
Int J Mol Sci. 2024 Dec; 25(23): 12886. Published online 2024 Nov 29. doi: 10.3390/ijms252312886
PMCID:
PMC11641039
ArticlePDF–2.5M
13.
Elucidating the causal links between plasma and cerebrospinal fluid metabolites and pituitary tumors: a Mendelian randomization analysis
Wencai Wang, Menghao Liu, Zun Wang, Wei Ye, Xianfeng Li
Front Endocrinol (Lausanne) 2024; 15: 1460278. Published online 2024 Nov 28. doi: 10.3389/fendo.2024.1460278
PMCID:
PMC11634583
ArticlePDF–6.1M
14.
The combination of serum lncRNA PTTG3P and mRNA PTTG1 serves as a diagnostic and prognostic marker for hepatocellular carcinoma
Shunwang Cao, Fei Zhong, Xueying Chen, Sikai Ke, Xiangrong Zhong, Tingting Li, Yanhua Sha, Chunmin Kang, Sheng Qin, Hongmei Wang, Yi Wang, Shuzhi Liao, Peifeng Ke
Mol Med Rep. 2025 Feb; 31(2): 44. Published online 2024 Nov 29. doi: 10.3892/mmr.2024.13409
PMCID:
PMC11632297
ArticlePDF–3.5M
15.
Inflammatory mediator contributes to leptin resistance and obesity in craniopharyngioma
Youchao Xiao, Wentao Wu, Fangzheng Liu, Lu Jin, Yanfei Jia, Ning Qiao, Kefan Cai, Siming Ru, Lei Cao, Songbai Gui
FASEB J. 2024 Dec 15; 38(23): e70242. Published online 2024 Dec 10. doi: 10.1096/fj.202402216RR
PMCID:
PMC11629452
ArticlePDF–12M
16.
The prospective roles of exosomes in pituitary tumors
Paulina Lisiewicz, Małgorzata Szelachowska, Adam Jacek Krętowski, Katarzyna Siewko
Front Endocrinol (Lausanne) 2024; 15: 1482756. Published online 2024 Nov 22. doi: 10.3389/fendo.2024.1482756
PMCID:
PMC11620868
ArticlePDF–697K
17.
The melanocortin receptor genes are linked to and associated with the risk of polycystic ovary syndrome in Italian families
Rongling Wu, Claudia Gragnoli
J Ovarian Res. 2024; 17: 242. Published online 2024 Dec 5. doi: 10.1186/s13048-024-01567-1
PMCID:
PMC11619144
ArticlePDF–990K
18.
Practical application of precision oncology in adult onset craniopharyngiomas
Chandrima Biswas, Guilherme Mansur, Kyle C. Wu, Daniel M. Prevedello, Luma Ghalib
Front Endocrinol (Lausanne) 2024; 15: 1488958. Published online 2024 Nov 20. doi: 10.3389/fendo.2024.1488958
PMCID:
PMC11615394
ArticlePDF–1.2M
19.
Ferroptosis-related biomarkers for adamantinomatous craniopharyngioma treatment: conclusions from machine learning techniques
Ying Feng, Zhen Zhang, Jiahao Tang, Yan Chen, Dan Hu, Xinwei Huang, Fangping Li
Front Endocrinol (Lausanne) 2024; 15: 1362278. Published online 2024 Nov 13. doi: 10.3389/fendo.2024.1362278
PMCID:
PMC11598535
ArticlePDF–10M
20.
The associations between risk factors and pituitary neuroendocrine tumors: A bidirectional Mendelian randomization study
Wencai Wang, Luyao Ma, Menghao Liu, Yongqiang Zhao, Wei Ye, Xianfeng Li
Medicine (Baltimore) 2024 Nov 22; 103(47): e40617. Published online 2024 Nov 22. doi: 10.1097/MD.0000000000040617
PMCID:
PMC11596971
ArticlePDF–1.8M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center